Skip to main content
. 2021 Sep 20;225(5):903–911. doi: 10.1093/infdis/jiab477

Table 1.

Characteristics of Study Participants and Factors Associated With Nonadherence to 12-Weeks of LDV/SOF

Characteristics Total (n = 105)a High Adherence (n = 76)b Low Adherence (n = 29)b Unadjusted Relative Risk (95% Confidence Interval) Adjusted Relative Risk (95% Confidence Interval)c
Treatment Groups
 Usual Care 23 (21.9) 18 (78.3) 5 (21.7) 1
 Peer 43 (41.0) 28 (65.1) 15 (34.9) 1.60 (0.67–3.87)
 Cash 39 (37.1) 30 (76.9) 9 (23.1) 1.06 (0.40–2.80)
Age
 <55 54 (51.4) 38 (70.4) 16 (29.6) 1
 ≥55 51 (48.6) 38 (74.5) 13 (25.5) 0.86 (0.46–1.61)
 Median (IQR) 54.9 (51.1–59.3) 55.1 (51.0–60.0) 54.1 (51.9–57.1) 0.98 (0.95–1.02)
Sex
 Male 62 (59.1) 46 (74.2) 16 (25.8) 1
 Female 43 (40.9) 30 (69.8) 13 (30.2) 1.17 (0.63–2.18)
Race
 Not Black 8 (7.6) 5 (62.5) 3 (37.5) 1
 Black 97 (92.4) 71 (73.2) 26 (26.8) 0.71 (0.27–1.86)
Employment Status
 Unemployed 85 (81.0) 61 (71.8) 24 (28.2) 1
 Employed 20 (19.0) 15 (75.0) 5 (25.0) 0.89 (0.38–2.04)
Alcohol Used
 PEth <50 ng/mL 65 (66.3) 54 (83.1) 11 (16.9) 1 1
 PEth ≥50 ng/mL 33 (33.7) 16 (48.5) 17 (15.5) 3.04 (1.61–5.75) 2.74 (1.48–5.08)
Self-Report Alcohol Use (AUDIT)
 Nonhazardous 78 (74.3) 59 (75.6) 19 (24.4) 1
 Hazardous 27 (25.7) 17 (63.0) 10 (37.0) 1.52 (0.81–2.86)
UTOX for Cocaine or Heroine
 Negative 56 (56.0) 42 (75.0) 14 (25.0) 1
 Positive 44 (44.0) 29 (65.9) 15 (34.1) 1.36 (0.74–2.52)
Self-Report Cocaine or Heroin
 No 82 (78.1) 61 (74.4) 21 (25.6) 1
 Yes 23 (21.9) 15 (65.2) 8 (34.8) 1.36 (0.69–2.66)
Depressionf
 CES-D <16 43 (41.0) 33 (76.7) 10 (23.3) 1
 CES-D ≥16 62 (59.0) 43 (69.3) 19 (30.7) 1.32 (0.68–2.56)
Emotional Supportg
 Low <33 41 (39.1) 24 (58.5) 17 (41.5) 1 1
 High ≥33 64 (60.9) 52 (81.2) 12 (18.8) 0.45 (0.24–0.85) 0.56 (0.31–1.01)
 Median (IQR) 36 (24–40) 38 (29–40) 30 (20–40) 0.96 (0.94–0.99)
Follow Provider’s Suggestionsh
 Never/rarely 11 (10.8) 4 (36.4) 7 (63.6) 1 1
 Sometimes 18 (17.7) 13 (72.2) 5 (27.8) 0.44 (0.18–1.04) 0.56 (0.23–1.35)
 Usually/always 73 (71.6) 57 (78.1) 16 (21.9) 0.34 (0.18–0.64) 0.46 (0.22–0.98)

Abbreviations: AUDIT, alcohol use disorders identification test; CES-D, Centers for Depression Epidemiology Scale; IQR, interquartile range; LDV/SOF, ledipasvir/sofosbuvir; PEth, phosphatidylethanol.

aUnless otherwise specified, numbers reported are n (%). For the “Total” column, the percentages represent the proportion with the specified characteristic of the total number of participants (ie, column percentages).

bUnless otherwise specified, numbers reported are n (%). For the “High Adherence” and “Low Adherence” columns, the percentages represent the proportion with high/low adherence of the total number of participants with the specified characteristic (ie, row percentages).

cOnly characteristics with a relative risk specified were included in the multivariable model.

dPEth reported for n = 98; missing 7 participants (4, high; 2, moderate; 1 low).

eUTOX reported for n = 100; missing 5 participants (3, high and 2, moderate).

fCenters for Depression Epidemiology Scale; active depression defined as score ≥16.

gPatient-Reported Outcomes Measurement Information System Short Form v2.0, Emotional Support 8a; high support defined as short form score ≥33. Questions assess whether participants have someone they trust and someone who listens and understands their problems.

hAnswered “How often do you follow your provider’s suggestions exactly?” with usually or always, n = 102.